Treatment of relapsed acute myeloid leukaemia after allogeneic bone marrow transplantation with combination chemotherapy of cytarabine, idarubicin plus etoposide and subsequent donor leukocyte infusion: a prospective study

被引:0
|
作者
Choi, SJ [1 ]
Lee, JH [1 ]
Lee, JH [1 ]
Kim, S [1 ]
Seol, M [1 ]
Lee, YS [1 ]
Lee, JS [1 ]
Kim, WK [1 ]
Lee, KH [1 ]
机构
[1] Asan Med Ctr, Seoul, South Korea
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S232 / S233
页数:2
相关论文
共 50 条
  • [31] Donor lymphocyte infusion for childhood acute lymphoblastic leukaemia relapsing after bone marrow transplantation
    Atra, A
    Millar, B
    Shepherd, V
    Shankar, A
    Wilson, K
    Treleaven, J
    PritchardJones, K
    Meller, ST
    Pinkerton, CR
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (01) : 165 - 168
  • [32] Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle
    Ruutu, T
    Koivunen, E
    Nousiainen, T
    Pelliniemi, TT
    Almqvist, A
    Anttila, P
    Jantunen, E
    Koistinen, P
    Koponen, A
    Mikkola, M
    Oksanen, K
    Pulli, T
    Remes, K
    Sarkkinen, R
    Silvennoinen, R
    Timonen, T
    Vanhatalo, S
    Elonen, E
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 72 (01) : 38 - 44
  • [33] Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation
    Loren, A. W.
    Porter, D. L.
    BONE MARROW TRANSPLANTATION, 2008, 41 (05) : 483 - 493
  • [34] Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation
    A W Loren
    D L Porter
    Bone Marrow Transplantation, 2008, 41 : 483 - 493
  • [35] Phase II Study of the Combination of Clofarabine Plus Idarubicin and Cytarabine (CIA) In Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
    Naqvi, Kiran
    Ravandi, Farhad
    Kantarjian, Hagop
    Borthakur, Gautam
    Ferrajoli, Alessandra
    Thomas, Deborah A.
    Koller, Charles Asa
    Konopleva, Marina
    Byrd, Anna
    Kwari, Monica
    Faderl, Stefan
    BLOOD, 2010, 116 (21) : 464 - 465
  • [36] Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program
    Miyamoto, Toshihiro
    Fukuda, Takahiro
    Nakashima, Marie
    Henzan, Tomoko
    Kusakabe, Shinsuke
    Kobayashi, Naoki
    Sugita, Junichi
    Mori, Takeshi
    Kurokawa, Mineo
    Mori, Shin-ichiro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (06) : 938 - 944
  • [37] Kinetics of the graft-versus-leukemia response after donor leukocyte infusions for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation
    Baurmann, H
    Nagel, S
    Binder, T
    Neubauer, A
    Siegert, V
    Huhn, D
    BLOOD, 1998, 92 (10) : 3582 - 3590
  • [38] Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study
    Karol, Seth E.
    Alexander, Thomas B.
    Budhraja, Amit
    Pounds, Stanley B.
    Canavera, Kristin
    Wang, Lei
    Wolf, Joshua
    Klco, Jeffery M.
    Mead, Paul E.
    Das Gupta, Soumyasri
    Kim, Su Y.
    Salem, Ahmed Hamed
    Palenski, Tammy
    Lacayo, Norman J.
    Pui, Ching-Hon
    Opferman, Joseph T.
    Rubnitz, Jeffrey E.
    LANCET ONCOLOGY, 2020, 21 (04): : 551 - 560
  • [39] Adoptive immunotherapy after bone marrow transplantation in a patient with relapsed acute myeloid leukaemia and severe psoriasis
    Windrum, P
    Jones, FGC
    McMullin, MF
    BONE MARROW TRANSPLANTATION, 2004, 34 (03) : 281 - 282
  • [40] Adoptive immunotherapy after bone marrow transplantation in a patient with relapsed acute myeloid leukaemia and severe psoriasis
    P Windrum
    F G C Jones
    M F McMullin
    Bone Marrow Transplantation, 2004, 34 : 281 - 282